Skin metabolism and transdermal absorption of viprostol, a synthetic PGE2 analog, in the rat: effect of vehicle
- PMID: 2627412
- DOI: 10.1159/000210798
Skin metabolism and transdermal absorption of viprostol, a synthetic PGE2 analog, in the rat: effect of vehicle
Abstract
The effects of three formulations on the transdermal absorption and antihypertensive activity of 14C-viprostol were investigated in the spontaneously hypertensive rat. Single doses of 14C-viprostol were administered topically to rats in three formulations: silicone oil, petrolatum base, and triethyl citrate (TEC). Mean arterial blood pressure (MABP) and blood concentrations of radioactivity were measured over 24 h. Metabolic profiles in the skin were determined by HPLC; in vitro skin metabolism was also investigated. Following topical dosing with 14C-viprostol in petrolatum and silicone oil, substantial systemic concentrations of radioactivity and decreases in MABP were observed. In contrast, administration of 14C-viprostol in TEC led to negligible blood concentrations of radioactivity and the lowering of MABP was diminished. Metabolic profiles in skin at the application site from rats dosed with viprostol in petrolatum and silicone oil indicated rapid hydrolysis of the viprostol methyl ester to the active free acid, CL 115,129. When TEC was used as the dosing vehicle, the conversion of viprostol to the free acid appeared to be slower. TEC (an ester itself) was also found to reduce the rate of hydrolysis of viprostol in rat skin 10,000-g supernatants.
Similar articles
-
Pre-systemic metabolism of viprostol in the monkey following oral and topical administration.Xenobiotica. 1988 Jul;18(7):797-802. doi: 10.3109/00498258809041718. Xenobiotica. 1988. PMID: 3176518
-
Deposition of viprostol (a synthetic PGE2 vasodilator) in the skin following topical administration to laboratory animals.Xenobiotica. 1987 Sep;17(9):1113-20. doi: 10.3109/00498258709044210. Xenobiotica. 1987. PMID: 3120427
-
Transdermal absorption and skin metabolism of viprostol, a synthetic prostaglandin E2 analogue.Drug Metab Rev. 1989-1990;21(3):401-25. doi: 10.3109/03602538909030304. Drug Metab Rev. 1989. PMID: 2701170 Review. No abstract available.
-
Mechanism of action of a new prostaglandin antihypertensive, viprostol [CL 115 347; (dl)-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl-prostaglandin E2 methyl ester]: (I). Vasodilation.J Hypertens. 1986 Dec;4(6):741-7. doi: 10.1097/00004872-198612000-00009. J Hypertens. 1986. PMID: 3029218
-
Mechanism of action of a new prostaglandin antihypertensive, viprostol [CL 115 347; (dl)-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl-prostaglandin E2 methyl ester]: (II). Effects on the adrenergic nervous system.J Hypertens. 1986 Dec;4(6):749-57. doi: 10.1097/00004872-198612000-00010. J Hypertens. 1986. PMID: 2880911
MeSH terms
Substances
LinkOut - more resources
Medical